Elekta states that Varian claims lack merit

STOCKHOLM, September 29, 2015 - Varian Medical Systems filed civil lawsuits and
made a request that the United States International Trade Commission (USITC)
initiate a patent infringement proceeding against Elekta on September 25, 2015.
Elekta states that the claims have no merit and will defend itself vigorously.
Elekta president and CEO Tomas Puusepp said: “We do not foresee any material
business impact as a result of these claims. They are apparently part of
Varian’s legal strategy against a lawsuit from William Beaumont Hospital and
Elekta Ltd. earlier this year.”
On June 16, 2015, William Beaumont Hospital and Elekta Ltd. filed a patent
infringement suit against Varian Medical Systems, Inc. in the United States
District Court for the Eastern District of Michigan. The patents in suit are
owned by William Beaumont Hospital and exclusively licensed to Elekta Ltd. The
suit charges that Varian's True Beam linear accelerator infringes the patents.
# # #
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242
Email: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 08:30 CET on September 29, 2015.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.